This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Santarus, Inc.. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Wayne Curtis Yount – Innovator in Antibody Formulations
Introduction
Wayne Curtis Yount, a distinguished inventor based in Franklinton, NC, has made significant contributions to the field of biopharmaceuticals. With an impressive portfolio of two patents, his work focuses primarily on antibody formulations that have the potential to advance therapeutic options.
Latest Patents
Yount's latest patents revolve around formulations of anti-VLA-1 antibodies. These patents detail the pharmaceutical compositions that utilize the anti-VLA1 (CD49A) antibody, showcasing innovative approaches to address medical challenges associated with this specific target. His work emphasizes the importance of precise formulations in the development of effective treatments.
Career Highlights
Wayne is currently employed at Santarus, Inc., where he continues to push the boundaries of antibody research and development. His commitment to innovation in biopharmaceuticals has positioned him as a valuable asset within the industry.
Collaborations
Throughout his career, Wayne has collaborated with several notable professionals, including his coworkers Adam Jeremy Fowler and Craig Michael Bowe. These partnerships reflect his dedication to collaborative research and the pursuit of groundbreaking biopharmaceutical solutions.
Conclusion
In summary, Wayne Curtis Yount is an influential inventor whose work in antibody formulations is paving the way for new therapeutic strategies. With his ongoing contributions at Santarus, Inc. and collaborative efforts with peers, Yount continues to make a significant impact in the field of biopharmaceutical innovation.